nitrates has been researched along with Fetal Growth Restriction in 13 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Exposure to drinking-water atrazine metabolites/nitrate mixture was divided into 6 classes according to the presence or absence of atrazine metabolites and to terciles of nitrate concentrations in each trimester of pregnancy." | 3.79 | Drinking-water exposure to a mixture of nitrate and low-dose atrazine metabolites and small-for-gestational age (SGA) babies: a historic cohort study. ( Albouy-Llaty, M; Carles, C; Dupuis, A; Limousi, F; Migeot, V; Rabouan, S; Strezlec, S, 2013) |
| " Whilst mechanisms underpinning impaired uteroplacental vascular function are not fully understood, interventions aimed at enhancing nitric oxide (NO) bioavailability remain a key area of interest in obstetric research." | 2.55 | Dietary interventions for fetal growth restriction - therapeutic potential of dietary nitrate supplementation in pregnancy. ( Cottrell, E; Greenwood, S; Johnstone, E; Myers, J; Ormesher, L; Sibley, C; Tropea, T; Wareing, M, 2017) |
| "Research on the pathogenesis of preeclampsia in several studies has established the involvement of the NO-system in preeclampsia and fetal intrauterine growth restriction (IUGR)." | 1.33 | Plasma- and urine concentrations of nitrite/nitrate and cyclic Guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies. ( Bidlingmaier, M; Friese, K; Jeschke, U; Kainer, F; Mylonas, I; Schiessl, B; Strasburger, C, 2006) |
| " The higher nitrate exposure categories were positively associated with intrauterine growth restriction and prematurity, and significant dose-response trends were seen, even after adjustment for several important covariates." | 1.31 | Agricultural contamination of groundwater as a possible risk factor for growth restriction or prematurity. ( Bryanton, J; Bukowski, J; Somers, G, 2001) |
| "In contrast, in preeclampsia and/or intrauterine growth restriction, moderate to intense nitrotyrosine immunostaining was seen in villous vascular endothelium, and immunostaining was also seen in surrounding vascular smooth muscle and villous stroma." | 1.29 | Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. ( Brockman, DE; Eis, AL; Greer, I; Lyall, F; Myatt, L; Rosenfield, RB, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Jensen, AS | 2 |
| Coffman, VR | 2 |
| Schullehner, J | 2 |
| Trabjerg, BB | 2 |
| Pedersen, CB | 2 |
| Hansen, B | 2 |
| Olsen, J | 2 |
| Pedersen, M | 2 |
| Stayner, LT | 2 |
| Sigsgaard, T | 2 |
| Ramos Gonzalez, M | 1 |
| DeConne, TM | 1 |
| Travis, OK | 1 |
| Baik, C | 1 |
| Tardo, GA | 1 |
| Amaral, L | 1 |
| Jackson, C | 1 |
| Greer, M | 1 |
| Giachelli, C | 1 |
| Ibrahim, T | 1 |
| Herrock, OT | 1 |
| Williams, JM | 1 |
| Cornelius, DC | 1 |
| Schaumburg, I | 1 |
| Tsikas, D | 1 |
| Bollenbach, A | 1 |
| Savvidou, MD | 1 |
| Cottrell, E | 1 |
| Tropea, T | 1 |
| Ormesher, L | 1 |
| Greenwood, S | 1 |
| Wareing, M | 1 |
| Johnstone, E | 1 |
| Myers, J | 1 |
| Sibley, C | 1 |
| Migeot, V | 1 |
| Albouy-Llaty, M | 1 |
| Carles, C | 1 |
| Limousi, F | 1 |
| Strezlec, S | 1 |
| Dupuis, A | 1 |
| Rabouan, S | 1 |
| Schiessl, B | 1 |
| Strasburger, C | 1 |
| Bidlingmaier, M | 1 |
| Mylonas, I | 1 |
| Jeschke, U | 1 |
| Kainer, F | 1 |
| Friese, K | 1 |
| Myatt, L | 1 |
| Rosenfield, RB | 1 |
| Eis, AL | 1 |
| Brockman, DE | 1 |
| Greer, I | 1 |
| Lyall, F | 1 |
| Miller, MJ | 1 |
| Voelker, CA | 1 |
| Olister, S | 1 |
| Thompson, JH | 1 |
| Zhang, XJ | 1 |
| Rivera, D | 1 |
| Eloby-Childress, S | 1 |
| Liu, X | 1 |
| Clark, DA | 1 |
| Pierce, MR | 1 |
| Greenberg, SS | 1 |
| Lancaster, JR | 1 |
| Xie, J | 1 |
| Sarphie, TG | 1 |
| Zhao, X | 1 |
| Hua, L | 1 |
| Freeman, T | 1 |
| Kapusta, DR | 1 |
| Giles, TD | 1 |
| Powers, DR | 1 |
| Bukowski, J | 1 |
| Somers, G | 1 |
| Bryanton, J | 1 |
| Litvinov, NN | 1 |
| Kazachkov, VI | 1 |
| Astakhova, LF | 1 |
| Gasimova, ZM | 1 |
| Zhurkov, VS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy L-arginine + L-citrulline as a Dietary Supplement vs Placebo for Weight Gain in Fetus With a Decrease in Their Growth Curve in the Third Trimester of Pregnancy[NCT05029778] | Phase 4 | 41 participants (Anticipated) | Interventional | 2021-10-20 | Not yet recruiting | ||
| First-trimester Placental Ultrasound Study (First PLUS): an Observational Cohort Study to Assess the Clinical Utility of the OxNNet Toolkit for the Prediction of Adverse Pregnancy Outcomes.[NCT05326191] | 4,000 participants (Actual) | Observational | 2022-03-15 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for nitrates and Fetal Growth Restriction
| Article | Year |
|---|---|
Dietary interventions for fetal growth restriction - therapeutic potential of dietary nitrate supplementation in pregnancy.
Topics: Animals; Diet; Dietary Supplements; Female; Fetal Growth Retardation; Humans; Maternal Nutritional P | 2017 |
Dietary interventions for fetal growth restriction - therapeutic potential of dietary nitrate supplementation in pregnancy.
Topics: Animals; Diet; Dietary Supplements; Female; Fetal Growth Retardation; Humans; Maternal Nutritional P | 2017 |
Dietary interventions for fetal growth restriction - therapeutic potential of dietary nitrate supplementation in pregnancy.
Topics: Animals; Diet; Dietary Supplements; Female; Fetal Growth Retardation; Humans; Maternal Nutritional P | 2017 |
Dietary interventions for fetal growth restriction - therapeutic potential of dietary nitrate supplementation in pregnancy.
Topics: Animals; Diet; Dietary Supplements; Female; Fetal Growth Retardation; Humans; Maternal Nutritional P | 2017 |
12 other studies available for nitrates and Fetal Growth Restriction
| Article | Year |
|---|---|
Prenatal exposure to tap water containing nitrate and the risk of small-for-gestational-age: A nationwide register-based study of Danish births, 1991-2015.
Topics: Child; Denmark; Drinking Water; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Maternal | 2023 |
Saying NO to fetal growth restriction: Implications for beetroot juice and melatonin.
Topics: Animals; Beta vulgaris; Blood Pressure; Female; Fetal Growth Retardation; Melatonin; Mice; Nitrates; | 2020 |
Adoptive transfer of placental ischemia-stimulated natural killer cells causes a preeclampsia-like phenotype in pregnant rats.
Topics: Adoptive Transfer; Animals; Cyclic GMP; Cytokines; Female; Fetal Growth Retardation; Ischemia; Kille | 2021 |
Prenatal Exposure to Nitrate from Drinking Water and Markers of Fetal Growth Restriction: A Population-Based Study of Nearly One Million Danish-Born Children.
Topics: Birth Weight; Child; Denmark; Drinking Water; Female; Fetal Growth Retardation; Humans; Nitrates; Pr | 2021 |
Inverse correlation between maternal plasma asymmetric dimethylarginine (ADMA) and birthweight percentile in women with impaired placental perfusion: circulating ADMA as an NO-independent indicator of fetal growth restriction?
Topics: Adult; Arginine; Biomarkers; Birth Weight; Female; Fetal Growth Retardation; Fetus; Gestational Age; | 2018 |
Drinking-water exposure to a mixture of nitrate and low-dose atrazine metabolites and small-for-gestational age (SGA) babies: a historic cohort study.
Topics: Adult; Atrazine; Cohort Studies; Drinking Water; Environmental Exposure; Female; Fetal Growth Retard | 2013 |
Plasma- and urine concentrations of nitrite/nitrate and cyclic Guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies.
Topics: Birth Weight; Cyclic GMP; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Nitrates; Nitri | 2006 |
Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action.
Topics: Adult; Drug Residues; Female; Fetal Growth Retardation; Humans; Immunohistochemistry; Nitrates; Plac | 1996 |
Fetal growth retardation in rats may result from apoptosis: role of peroxynitrite.
Topics: Animals; Apoptosis; Base Sequence; DNA Primers; Endotoxins; Enzyme Inhibitors; Female; Fetal Growth | 1996 |
Effects of NO synthase inhibitors, arginine-deficient diet, and amiloride in pregnant rats.
Topics: Abnormalities, Drug-Induced; Amiloride; Analysis of Variance; Animals; Arginine; Female; Fetal Death | 1997 |
Agricultural contamination of groundwater as a possible risk factor for growth restriction or prematurity.
Topics: Agriculture; Case-Control Studies; Dose-Response Relationship, Drug; Female; Fetal Growth Retardatio | 2001 |
[Benzol and lead nitrate as modifiers of the embryotoxic effect of cadmium chloride].
Topics: Animals; Benzene; Cadmium; Cadmium Chloride; Dose-Response Relationship, Drug; Drug Synergism; Femal | 1991 |